NR4A1 and breast carcinoma: The methylation status of the six-gene panel in the breast cancer patients of the test set was further analyzed for association with known clinicopathologic characteristics of breast cancer, including age at diagnosis, family history of tumors, tumor grade, tumor size, node status, and hormone-receptor status, etc (Table 2).